2000 Decriminalization Microdosing Treatment 
Veriheal
MARCH 20, 2023
Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Johns Hopkins University first received regulatory approval for psychedelic research in the year 2000. Minnesota Rep. Missouri Rep.
Cannabis Law Report
JUNE 4, 2021
there has never been a better time for new treatment options. Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009. She is interested in the theme of ‘connectedness to Self, others, and the world’ as an important aspect of psychedelic treatment.
Expert insights. Personalized for you.
98 
Let's personalize your content